{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T05:54:19Z","timestamp":1777182859842,"version":"3.51.4"},"reference-count":160,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010211","name":"Education Department of Jilin Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010211","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.thromres.2020.10.005","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T07:47:37Z","timestamp":1602143257000},"page":"500-509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Why thromboembolism occurs in some patients with thrombocytopenia and treatment strategies"],"prefix":"10.1016","volume":"196","author":[{"given":"Xiaorong","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojie","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonggang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2020.10.005_bb0005","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11239-016-1467-8","article-title":"Etiology and complications of thrombocytopenia in hospitalized medical patients","volume":"43","author":"Fountain","year":"2017","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2020.10.005_bb0010","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/00003246-200006000-00031","article-title":"Thrombocytopenia and prognosis in intensive care","volume":"28","author":"Vanderschueren","year":"2000","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.thromres.2020.10.005_bb0015","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jcrc.2005.09.008","article-title":"Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors","volume":"20","author":"Crowther","year":"2005","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.thromres.2020.10.005_bb0020","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4149\/endo_2014_04_182","article-title":"Assessment of mean platelet volume (MPV) in primary hyperparathyroidism: effects of successful parathyroidectomy on MPV levels","volume":"48","author":"Yilmaz","year":"2014","journal-title":"Endocr. Regul."},{"key":"10.1016\/j.thromres.2020.10.005_bb0025","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/jth.14788","article-title":"Large and small platelets-(when) do they differ?","volume":"18","author":"Handtke","year":"2020","journal-title":"Journal of thrombosis and haemostasis\u202f: JTH."},{"key":"10.1016\/j.thromres.2020.10.005_bb0030","series-title":"Thrombosis. StatPearls","author":"Ashorobi","year":"2020"},{"key":"10.1016\/j.thromres.2020.10.005_bb0035","series-title":"Thrombocytopenia. StatPearls","author":"Jinna","year":"2020"},{"key":"10.1016\/j.thromres.2020.10.005_bb0040","first-page":"260","article-title":"MYH-9 related platelet disorders: strategies for management and diagnosis","volume":"37","author":"Althaus","year":"2010","journal-title":"Transfusion medicine and hemotherapy\u202f: offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie."},{"key":"10.1016\/j.thromres.2020.10.005_bb0045","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2017.038","article-title":"Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia","volume":"9","author":"Guison","year":"2017","journal-title":"Mediterranean journal of hematology and infectious diseases."},{"key":"10.1016\/j.thromres.2020.10.005_bb0050","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ejmg.2018.01.014","article-title":"Clinic, pathogenic mechanisms and drug testing of two inherited thrombocytopenias, ANKRD26-related thrombocytopenia and MYH9-related diseases","volume":"61","author":"Balduini","year":"2018","journal-title":"European journal of medical genetics."},{"key":"10.1016\/j.thromres.2020.10.005_bb0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.blre.2017.03.005","article-title":"Should studies on Glanzmann thrombasthenia not be telling us more about cardiovascular disease and other major illnesses?","volume":"31","author":"Nurden","year":"2017","journal-title":"Blood Rev."},{"key":"10.1016\/j.thromres.2020.10.005_bb0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1750-1172-1-46","article-title":"Bernard-Soulier syndrome (hemorrhagiparous thrombocytic dystrophy)","volume":"1","author":"Lanza","year":"2006","journal-title":"Orphanet journal of rare diseases."},{"key":"10.1016\/j.thromres.2020.10.005_bb0065","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11239-012-0742-6","article-title":"Myocardial infarction in two cousins heterozygous for ASN41HIS autosomal dominant variant of Bernard-Soulier syndrome","volume":"34","author":"Girolami","year":"2012","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2020.10.005_bb0070","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.3324\/haematol.2019.216796","article-title":"The international hereditary thrombotic thrombocytopenic purpura registry: key findings at enrollment until 2017","volume":"104","author":"van Dorland","year":"2019","journal-title":"Haematologica."},{"key":"10.1016\/j.thromres.2020.10.005_bb0075","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1182\/asheducation-2014.1.444","article-title":"Thrombotic microangiopathy and indications for therapeutic plasma exchange","volume":"2014","author":"Adamski","year":"2014","journal-title":"Hematology American Society of Hematology Education Program."},{"key":"10.1016\/j.thromres.2020.10.005_bb0080","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","article-title":"Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies","volume":"158","author":"Scully","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0085","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/pbc.24612","article-title":"Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features","volume":"60","author":"Reese","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.thromres.2020.10.005_bb0090","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/ped.13044","article-title":"Clinical guides for atypical hemolytic uremic syndrome in Japan","volume":"58","author":"Kato","year":"2016","journal-title":"Pediatrics international\u202f: official journal of the Japan Pediatric Society."},{"key":"10.1016\/j.thromres.2020.10.005_bb0095","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2215\/CJN.11470918","article-title":"Etiology and outcomes of thrombotic microangiopathies","volume":"14","author":"Bayer","year":"2019","journal-title":"Clinical journal of the American Society of Nephrology\u202f: CJASN."},{"key":"10.1016\/j.thromres.2020.10.005_bb0100","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12959-018-0168-2","article-title":"Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy","volume":"16","author":"Wada","year":"2018","journal-title":"Thromb. J."},{"key":"10.1016\/j.thromres.2020.10.005_bb0105","doi-asserted-by":"crossref","first-page":"16037","DOI":"10.1038\/nrdp.2016.37","article-title":"Disseminated intravascular coagulation","volume":"2","author":"Gando","year":"2016","journal-title":"Nature reviews Disease primers."},{"key":"10.1016\/j.thromres.2020.10.005_bb0110","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood advances."},{"key":"10.1016\/j.thromres.2020.10.005_bb0115","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/bjh.12318","article-title":"Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies","volume":"161","author":"Kim","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0120","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.seminhematol.2008.12.005","article-title":"Pathobiology of secondary immune thrombocytopenia","volume":"46","author":"Cines","year":"2009","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0125","doi-asserted-by":"crossref","unstructured":"Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet (London, England). 2010;376:1498\u2013509.","DOI":"10.1016\/S0140-6736(10)60709-X"},{"key":"10.1016\/j.thromres.2020.10.005_bb0130","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/art.40901","article-title":"The epidemiology of antiphospholipid syndrome: a population-based study","volume":"71","author":"Duarte-Garc\u00eda","year":"2019","journal-title":"Arthritis & rheumatology (Hoboken, NJ)"},{"key":"10.1016\/j.thromres.2020.10.005_bb0135","first-page":"171","article-title":"Autoimmune diseases and venous thromboembolism: a review of the literature","volume":"2","author":"Zoller","year":"2012","journal-title":"American journal of cardiovascular disease."},{"key":"10.1016\/j.thromres.2020.10.005_bb0140","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3899\/jrheum.171459","article-title":"Canadian rheumatology association recommendations for the assessment and monitoring of systemic lupus erythematosus","volume":"45","author":"Keeling","year":"2018","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0145","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","article-title":"The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies","volume":"56","author":"Rees","year":"2017","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.thromres.2020.10.005_bb0150","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0167-5273(98)00043-6","article-title":"Functional compensation of the low platelet count by increased individual platelet size in a patient with May-Hegglin anomaly presenting with acute myocardial infarction","volume":"64","author":"Goto","year":"1998","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0155","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1160\/TH10-01-0041","article-title":"Intriguing outcome of JAK2V617F mutation seen in a patient with MYH9-related hereditary macrothrombocytopenia","volume":"104","author":"Fabris","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.10.005_bb0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/09537104.2012.758360","article-title":"Cardiac and pulmonary thrombosis during multidrug treatment in an idiopathic thrombocytopenic purpura patient","volume":"25","author":"Andic","year":"2014","journal-title":"Platelets."},{"key":"10.1016\/j.thromres.2020.10.005_bb0165","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.15264\/cpho.2017.24.1.11","article-title":"Dural venous sinus thrombosis and pulmonary embolism following immunoglobulin treatment in pediatric patient with immune thrombocytopenic purpura","volume":"39","author":"Park","year":"2017","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2020.10.005_bb0170","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.thromres.2012.08.282","article-title":"Thrombosis in patients with primary chronic immune thrombocytopenia","volume":"130","author":"Norgaard","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.10.005_bb0175","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1182\/asheducation-2018.1.576","article-title":"Drug-associated thrombocytopenia","volume":"2018","author":"Bakchoul","year":"2018","journal-title":"Hematology American Society of Hematology Education Program."},{"key":"10.1016\/j.thromres.2020.10.005_bb0180","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/09537104.2017.1294250","article-title":"MYH9 gene mutations associated with bleeding","volume":"28","author":"Savoia","year":"2017","journal-title":"Platelets."},{"key":"10.1016\/j.thromres.2020.10.005_bb0185","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3109\/09537104.2016.1171305","article-title":"Clinical and laboratory characteristics in congenital ANKRD26 mutation-associated thrombocytopenia: a detailed phenotypic study of a family","volume":"27","author":"Perez Botero","year":"2016","journal-title":"Platelets."},{"key":"10.1016\/j.thromres.2020.10.005_bb0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bcmd.2017.01.010","article-title":"Patients with Bernard-Soulier syndrome and different severity of the bleeding phenotype","volume":"67","author":"Boeckelmann","year":"2017","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.thromres.2020.10.005_bb0195","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ajh.25472","article-title":"MYH9-related disease mutations cause abnormal red blood cell morphology through increased myosin-actin binding at the membrane","volume":"94","author":"Smith","year":"2019","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0200","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1272\/jnms.75.228","article-title":"Cerebral infarction in a patient with macrothrombocytopenia with leukocyte inclusions (MTCP, May-Hegglin anomaly\/Sebastian syndrome)","volume":"75","author":"Nishiyama","year":"2008","journal-title":"Journal of Nippon Medical School = Nippon Ika Daigaku zasshi."},{"key":"10.1016\/j.thromres.2020.10.005_bb0205","first-page":"214","article-title":"Primary angioplasty in a patient with the May-Hegglin anomaly, a rare heredity thrombocytopenia. A case report and review of the literature","volume":"6","author":"Varbella","year":"2005","journal-title":"Italian heart journal Supplement\u202f: official journal of the Italian Federation of Cardiology."},{"key":"10.1016\/j.thromres.2020.10.005_bb0210","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood-2011-06-358853","article-title":"Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A","volume":"119","author":"Zhang","year":"2012","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2020.10.005_bb0215","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/jth.12436","article-title":"The abnormal proplatelet formation in MYH9-related macrothrombocytopenia results from an increased actomyosin contractility and is rescued by myosin IIA inhibition","volume":"11","author":"Chen","year":"2013","journal-title":"Journal of thrombosis and haemostasis\u202f: JTH."},{"key":"10.1016\/j.thromres.2020.10.005_bb0220","doi-asserted-by":"crossref","first-page":"22205","DOI":"10.1073\/pnas.1909227116","article-title":"Cellular defects resulting from disease-related myosin II mutations in Drosophila","volume":"116","author":"Kasza","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.thromres.2020.10.005_bb0225","volume":"8","author":"Heuze","year":"2019","journal-title":"Myosin II isoforms play distinct roles in adherens junction biogenesis."},{"key":"10.1016\/j.thromres.2020.10.005_bb0230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jrr\/rru070","article-title":"Dose- and time-dependent gene expression alterations in prostate and colon cancer cells after in vitro exposure to carbon ion and X-irradiation","volume":"56","author":"Suetens","year":"2015","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.thromres.2020.10.005_bb0235","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/elps.201200596","article-title":"Identification of stromal differentially expressed proteins in the colon carcinoma by quantitative proteomics","volume":"34","author":"Mu","year":"2013","journal-title":"Electrophoresis."},{"key":"10.1016\/j.thromres.2020.10.005_bb0240","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.jid.2019.03.1151","article-title":"Malta (MYH9 associated elastin aggregation) syndrome: germline variants in MYH9 cause rare sweat duct proliferations and irregular elastin aggregations","volume":"139","author":"Fewings","year":"2019","journal-title":"The Journal of investigative dermatology"},{"key":"10.1016\/j.thromres.2020.10.005_bb0245","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.bbrc.2010.12.069","article-title":"Nonmuscle myosin IIA is required for lamellipodia formation through binding to WAVE2 and phosphatidylinositol 3,4,5-triphosphate","volume":"404","author":"Morimura","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.thromres.2020.10.005_bb0250","doi-asserted-by":"crossref","first-page":"888","DOI":"10.12659\/MSM.912320","article-title":"Myosin heavy chain 9: oncogene or tumor suppressor gene?","volume":"25","author":"Wang","year":"2019","journal-title":"Medical science monitor\u202f: international medical journal of experimental and clinical research."},{"key":"10.1016\/j.thromres.2020.10.005_bb0255","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1182\/blood-2011-02-336537","article-title":"Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families","volume":"117","author":"Noris","year":"2011","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2020.10.005_bb0260","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.3109\/10428194.2014.903476","article-title":"A new family with a germline ANKRD26 mutation and predisposition to myeloid malignancies","volume":"55","author":"Marquez","year":"2014","journal-title":"Leukemia & lymphoma."},{"key":"10.1016\/j.thromres.2020.10.005_bb0265","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1160\/TH12-07-0497","article-title":"Ubiquitin\/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia","volume":"109","author":"Necchi","year":"2013","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.10.005_bb0270","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1160\/TH13-01-0025","article-title":"Polyubiquinated protein depots in platelets and megakaryocytes from patients with ANKRD26-RT","volume":"109","author":"Kraemer","year":"2013","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.10.005_bb0275","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajhg.2010.12.006","article-title":"Mutations in the 5\u2032 UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2","volume":"88","author":"Pippucci","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.thromres.2020.10.005_bb0280","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1172\/JCI71861","article-title":"Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation","volume":"124","author":"Bluteau","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2020.10.005_bb0285","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-4615-1277-6_2","article-title":"Are patients with Glanzmann thrombasthenia and the Bernard-Soulier syndrome protected against atherosclerosis?","volume":"489","author":"Nurden","year":"2001","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0290","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-0038-1676348","article-title":"Low concentrations of recombinant factor VIIa may improve the impaired thrombin generation of Glanzmann thrombasthenia patients","volume":"119","author":"Levy-Mendelovich","year":"2019","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.10.005_bb0295","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1182\/blood-2011-07-365635","article-title":"Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models","volume":"118","author":"Nurden","year":"2011","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2020.10.005_bb0300","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/MBC.0b013e32834a5c4c","article-title":"Formation of obstructing blood clot in the ureter in a patient with Glanzmann\u2019s thrombasthenia","volume":"22","author":"Kilincaslan","year":"2011","journal-title":"Blood coagulation & fibrinolysis\u202f: an international journal in haemostasis and thrombosis."},{"key":"10.1016\/j.thromres.2020.10.005_bb0305","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1182\/blood.V90.2.888","article-title":"Severe proximal deep vein thrombosis in a Glanzmann thrombasthenia variant successfully treated with a low molecular weight heparin","volume":"90","author":"Gruel","year":"1997","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2020.10.005_bb0310","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/MBC.0000000000000241","article-title":"Abnormal cytoplasmic extensions associated with active alphaIIbbeta3 are probably the cause for macrothrombocytopenia in Glanzmann thrombasthenia-like syndrome","volume":"26","author":"Hauschner","year":"2015","journal-title":"Blood coagulation & fibrinolysis\u202f: an international journal in haemostasis and thrombosis."},{"key":"10.1016\/j.thromres.2020.10.005_bb0315","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1538-7836.2003.00041.x","article-title":"The role of platelets in venous thrombosis: a patient with Glanzmann\u2019s thrombasthenia and a factor V Leiden mutation suffering from deep venous thrombosis","volume":"1","author":"Ten Cate","year":"2003","journal-title":"Journal of thrombosis and haemostasis\u202f: JTH."},{"key":"10.1016\/j.thromres.2020.10.005_bb0320","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/MBC.0b013e3283597634","article-title":"Occurrence of thrombosis in congenital thrombocytopenic disorders: a critical annotation of the literature","volume":"24","author":"Girolami","year":"2013","journal-title":"Blood coagulation & fibrinolysis\u202f: an international journal in haemostasis and thrombosis."},{"key":"10.1016\/j.thromres.2020.10.005_bb0325","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ehjcvp\/pvu008","article-title":"Risk of thrombocytopenia with glycoprotein IIb\/IIIa inhibitors across drugs and patient populations: a meta-analysis of 29 large placebo-controlled randomized trials","volume":"1","author":"Wessler","year":"2015","journal-title":"European heart journal Cardiovascular pharmacotherapy."},{"key":"10.1016\/j.thromres.2020.10.005_bb0330","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0268-960X(02)00030-9","article-title":"Molecular basis of Glanzmann\u2019s Thrombasthenia and current strategies in treatment","volume":"16","author":"Bellucci","year":"2002","journal-title":"Blood Rev."},{"key":"10.1016\/j.thromres.2020.10.005_bb0335","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/0953710021000024394","article-title":"Glanzmann\u2019s thrombasthenia: updated","volume":"13","author":"Nair","year":"2002","journal-title":"Platelets."},{"key":"10.1016\/j.thromres.2020.10.005_bb0340","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ijcard.2005.11.094","article-title":"Glanzmann thrombasthenia with endomyocardial fibrosis: a thrombotic paradox","volume":"114","author":"Tullu","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0345","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1046\/j.1365-2141.2002.03966.x","article-title":"Dissociation between fibrinogen and fibrin interaction with platelets in patients with different subtypes of Glanzmann\u2019s thrombasthenia: studies in an ex vivo perfusion chamber model","volume":"119","author":"Hainaud","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0350","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1182\/blood.V101.3.929","article-title":"Dynamics of GPIIb\/IIIa-mediated platelet-platelet interactions in platelet adhesion\/thrombus formation on collagen in vitro as revealed by videomicroscopy","volume":"101","author":"Patel","year":"2003","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2020.10.005_bb0355","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/jth.13355","article-title":"Lentiviral gene rescue of a Bernard-Soulier mouse model to study platelet glycoprotein Ibbeta function","volume":"14","author":"Strassel","year":"2016","journal-title":"Journal of thrombosis and haemostasis\u202f: JTH."},{"key":"10.1016\/j.thromres.2020.10.005_bb0360","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/jth.12144","article-title":"The organizing principle of the platelet glycoprotein Ib-IX-V complex","volume":"11","author":"Li","year":"2013","journal-title":"Journal of thrombosis and haemostasis\u202f: JTH."},{"key":"10.1016\/j.thromres.2020.10.005_bb0365","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1055\/s-0033-1353390","article-title":"Bernard-Soulier syndrome: an update","volume":"39","author":"Andrews","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2020.10.005_bb0370","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/01.ATV.0000251992.47053.75","article-title":"Decreased thrombotic tendency in mouse models of the Bernard-Soulier syndrome","volume":"27","author":"Strassel","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0375","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1182\/blood.V67.2.322.322","article-title":"Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules","volume":"67","author":"Weiss","year":"1986","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2020.10.005_bb0380","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1365-2141.1986.tb07552.x","article-title":"The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium","volume":"63","author":"Sakariassen","year":"1986","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0385","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/ajcp\/97.5.652","article-title":"Atherosclerosis and unstable angina in Bernard-Soulier syndrome","volume":"97","author":"Humphries","year":"1992","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0390","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/hc0902.104676","article-title":"Patients with Glanzmann thrombasthenia lacking platelet glycoprotein alpha(IIb)beta(3) (GPIIb\/IIIa) and alpha(v)beta(3) receptors are not protected from atherosclerosis","volume":"105","author":"Shpilberg","year":"2002","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.thromres.2020.10.005_bb0395","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/vox.12879","article-title":"Pro-inflammatory effects after platelet transfusion: a review","volume":"115","author":"Chen","year":"2020","journal-title":"Vox Sang."},{"key":"10.1016\/j.thromres.2020.10.005_bb0400","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-0032-1333540","article-title":"Diagnosis and management of inherited thrombocytopenias","volume":"39","author":"Balduini","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2020.10.005_bb0405","first-page":"374","article-title":"Inherited thrombocytopenias","volume":"20","author":"Balduini","year":"2015","journal-title":"Hematology (Amsterdam, Netherlands)"},{"key":"10.1016\/j.thromres.2020.10.005_bb0410","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0029-1220327","article-title":"MYH9-related platelet disorders","volume":"35","author":"Althaus","year":"2009","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2020.10.005_bb0415","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11239-011-0623-4","article-title":"Thrombotic events in MYH9 gene-related autosomal macrothrombocytopenias (old May-Hegglin, Sebastian, Fechtner and Epstein syndromes)","volume":"32","author":"Girolami","year":"2011","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2020.10.005_bb0420","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/17476930500467235","article-title":"Unexplained recurrent venous thrombosis in a patient with MYH9-related disease","volume":"17","author":"Heller","year":"2006","journal-title":"Platelets."},{"key":"10.1016\/j.thromres.2020.10.005_bb0425","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1365-2141.2011.08821.x","article-title":"Secondary prophylaxis with warfarin for recurrent thrombosisin a patient with Glanzmann thrombasthenia andF5G1691A.pdf","volume":"156","author":"SM R","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0430","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/nep.13234","article-title":"Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand","volume":"23","author":"Fox","year":"2018","journal-title":"Nephrology (Carlton, Vic)"},{"key":"10.1016\/j.thromres.2020.10.005_bb0435","doi-asserted-by":"crossref","first-page":"218","DOI":"10.5045\/br.2019.54.3.218","article-title":"Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura","volume":"54","author":"Oh","year":"2019","journal-title":"Blood research."},{"key":"10.1016\/j.thromres.2020.10.005_bb0440","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood-2014-11-611335","article-title":"Drug-induced thrombotic microangiopathy: a systematic review of published reports","volume":"125","author":"Al-Nouri","year":"2015","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2020.10.005_bb0445","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2020.10.005_bb0450","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation","volume":"8","author":"Noris","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0455","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1084\/jem.147.6.1713","article-title":"The human complement system in thrombin-mediated platelet function","volume":"147","author":"Polley","year":"1978","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.thromres.2020.10.005_bb0460","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1084\/jem.158.2.603","article-title":"Human platelet activation by C3a and C3a des-arg","volume":"158","author":"Polley","year":"1983","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.thromres.2020.10.005_bb0465","first-page":"191","article-title":"The role of complement activation in thrombosis and hemolytic anemias","volume":"54","author":"Chapin","year":"2016","journal-title":"Transfusion and apheresis science\u202f: official journal of the World Apheresis Association\u202f: official journal of the European Society for Haemapheresis."},{"key":"10.1016\/j.thromres.2020.10.005_bb0470","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2141.2008.07276.x","article-title":"Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features","volume":"142","author":"Scully","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0475","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/jth.13716","article-title":"Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura","volume":"15","author":"Peyvandi","year":"2017","journal-title":"Journal of thrombosis and haemostasis\u202f: JTH."},{"key":"10.1016\/j.thromres.2020.10.005_bb0480","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1160\/TH17-06-0404","article-title":"Insights into 3D structure of ADAMTS13: a stepping stone towards novel therapeutic treatment of thrombotic thrombocytopenic purpura","volume":"118","author":"Ercig","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.10.005_bb0485","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.thromres.2017.10.007","article-title":"Highly elevated plasma level of von Willebrand factor accelerates the formation of platelet thrombus under high shear stress in plasma with deficient ADAMTS13 activity","volume":"159","author":"Yagi","year":"2017","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.10.005_bb0490","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1182\/blood-2008-07-169359","article-title":"The distal carboxyl-terminal domains of ADAMTS13 are required for regulation of in vivo thrombus formation","volume":"113","author":"Banno","year":"2009","journal-title":"Blood."},{"issue":"132","key":"10.1016\/j.thromres.2020.10.005_bb0495","first-page":"e3","article-title":"Successful resuscitation with thrombolysis of pulmonary embolism due to thrombotic thrombocytopenic purpura during cardiac arrest","volume":"33","author":"Zhu","year":"2015","journal-title":"The American journal of emergency medicine"},{"key":"10.1016\/j.thromres.2020.10.005_bb0500","first-page":"1073","article-title":"Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.thromres.2020.10.005_bb0505","first-page":"172","article-title":"Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis","volume":"187","author":"Morigi","year":"2011","journal-title":"Journal of immunology (Baltimore, Md\u202f: 1950)"},{"key":"10.1016\/j.thromres.2020.10.005_bb0510","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1084\/jem.20041497","article-title":"Platelet activation leads to activation and propagation of the complement system","volume":"201","author":"Del Conde","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.thromres.2020.10.005_bb0515","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.ajog.2007.12.034","article-title":"HELLP syndrome: an atypical presentation","volume":"198","author":"Stella","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0520","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/ard.2006.061671","article-title":"Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases","volume":"66","author":"Gomez-Puerta","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.thromres.2020.10.005_bb0525","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijoa.2015.01.006","article-title":"Pulmonary embolism in the setting of HELLP syndrome","volume":"24","author":"Prin","year":"2015","journal-title":"Int. J. Obstet. Anesth."},{"key":"10.1016\/j.thromres.2020.10.005_bb0530","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ajh\/4.8.700","article-title":"Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia","volume":"4","author":"Roberts","year":"1991","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.thromres.2020.10.005_bb0535","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/pgmj.55.643.362","article-title":"Blood clotting and fibrinolysis in pregnancy","volume":"55","author":"Howie","year":"1979","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.thromres.2020.10.005_bb0540","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2004.08.004","article-title":"Haemostatic changes in pregnancy","volume":"114","author":"Brenner","year":"2004","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.10.005_bb0545","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1538-7836.2010.03862.x","article-title":"Massive pulmonary embolism leading to cardiac arrest is associated with consumptive coagulopathy presenting as disseminated intravascular coagulation","volume":"8","author":"Leitner","year":"2010","journal-title":"Journal of thrombosis and haemostasis\u202f: JTH."},{"issue":"123","key":"10.1016\/j.thromres.2020.10.005_bb0550","first-page":"e1","article-title":"Practice guidelines for the emergency treatment of thrombotic microangiopathy","volume":"151","author":"Romero","year":"2018","journal-title":"Medicina clinica"},{"key":"10.1016\/j.thromres.2020.10.005_bb0555","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12185-017-2264-7","article-title":"Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan","volume":"106","author":"Matsumoto","year":"2017","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0560","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.thromres.2011.08.028","article-title":"Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)","volume":"129","author":"Di Nisio","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.10.005_bb0565","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0968-0004(01)02007-2","article-title":"Evolution of enzyme cascades from embryonic development to blood coagulation","volume":"27","author":"Krem","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.thromres.2020.10.005_bb0570","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00277-014-2292-9","article-title":"Refractory mixed autoimmune hemolysis, thrombocytopenia, and thrombosis: a diagnostic puzzle","volume":"94","author":"Klassen","year":"2015","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0575","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.pop.2016.07.008","article-title":"Thrombocytopenia","volume":"43","author":"Lee","year":"2016","journal-title":"Primary care."},{"key":"10.1016\/j.thromres.2020.10.005_bb0580","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.thromres.2020.01.020","article-title":"Why do patients with immune thrombocytopenia (ITP) experience lower bleeding events despite thrombocytopenia?","volume":"187","author":"Boulware","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.10.005_bb0585","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/bjh.14412","article-title":"Procoagulant profile in patients with immune thrombocytopenia","volume":"175","author":"Alvarez-Roman","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0590","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/1076029612452114","article-title":"Arterial and venous thromboses in patients with idiopathic (immunological) thrombocytopenia: a possible contributing role of cortisone-induced hypercoagulable state","volume":"19","author":"Girolami","year":"2013","journal-title":"Clinical and applied thrombosis\/hemostasis\u202f: official journal of the International Academy of Clinical and Applied Thrombosis\/Hemostasis."},{"key":"10.1016\/j.thromres.2020.10.005_bb0595","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/000331970505600215","article-title":"Thrombocytopenia, immunoglobulin treatment, and acute myocardial infarction--a case report","volume":"56","author":"Amit","year":"2005","journal-title":"Angiology."},{"key":"10.1016\/j.thromres.2020.10.005_bb0600","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1056\/NEJMcp1810479","article-title":"Immune thrombocytopenia","volume":"381","author":"Cooper","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2020.10.005_bb0605","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11239-009-0431-2","article-title":"Recurrent ischemic stroke in a patient with idiopathic thrombocytopenic purpura","volume":"30","author":"Rhee","year":"2010","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2020.10.005_bb0610","doi-asserted-by":"crossref","first-page":"E293","DOI":"10.1002\/ajh.24341","article-title":"Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study","volume":"91","author":"Zaja","year":"2016","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0615","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2016.10.012","article-title":"Recurrent pulmonary embolism during dabigatran treatment in a patient with immune thrombocytopenic purpura","volume":"148","author":"Kang","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.10.005_bb0620","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1191\/0961203305lu2145rr","article-title":"Antiphospholipid antibody associated thrombocytopenia and the paradoxical risk of thrombosis","volume":"14","author":"Atsumi","year":"2005","journal-title":"Lupus."},{"key":"10.1016\/j.thromres.2020.10.005_bb0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00281-011-0298-0","article-title":"Coagulation and inflammation--close allies in health and disease","volume":"34","author":"Dahlback","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0630","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-physiol-012110-142300","article-title":"The link between vascular features and thrombosis","volume":"73","author":"Esmon","year":"2011","journal-title":"Annu. Rev. Physiol."},{"issue":"5\u20136","key":"10.1016\/j.thromres.2020.10.005_bb0635","first-page":"8","article-title":"Inflammation, innate immunity and blood coagulation","volume":"30","author":"Xu","year":"2010","journal-title":"Hamostaseologie."},{"key":"10.1016\/j.thromres.2020.10.005_bb0640","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-3083.2007.01984.x","article-title":"The role of microparticles in inflammation and thrombosis","volume":"66","author":"Ardoin","year":"2007","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0645","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(11)61306-8","article-title":"Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden","volume":"379","author":"Zoller","year":"2012","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.thromres.2020.10.005_bb0650","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrrheum.2010.47","article-title":"Antiphospholipid syndrome: frequency, main causes and risk factors of mortality","volume":"6","author":"Espinosa","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0655","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0660","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11926-004-0024-1","article-title":"What is antiphospholipid syndrome?","volume":"6","author":"Erkan","year":"2004","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.thromres.2020.10.005_bb0665","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1111\/j.1538-7836.2005.01485.x","article-title":"Lupus anticoagulants and the risk of a first episode of deep venous thrombosis","volume":"3","author":"de Groot","year":"2005","journal-title":"Journal of thrombosis and haemostasis\u202f: JTH."},{"key":"10.1016\/j.thromres.2020.10.005_bb0670","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.thromres.2008.11.003","article-title":"Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry","volume":"124","author":"Roldan","year":"2009","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.10.005_bb0675","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11926-007-0031-0","article-title":"Mechanisms of aPL-mediated thrombosis: effects of aPL on endothelium and platelets","volume":"9","author":"Vega-Ostertag","year":"2007","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.thromres.2020.10.005_bb0680","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jaut.2010.06.015","article-title":"A novel mechanism of thrombosis in antiphospholipid antibody syndrome","volume":"35","author":"Vlachoyiannopoulos","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.thromres.2020.10.005_bb0685","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1055\/s-0035-1556587","article-title":"Thrombosis, Microangiopathies, and inflammation","volume":"41","author":"Matevosyan","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2020.10.005_bb0690","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2014-000078","article-title":"Haematological manifestations of lupus","volume":"2","author":"Fayyaz","year":"2015","journal-title":"Lupus science & medicine."},{"key":"10.1016\/j.thromres.2020.10.005_bb0695","doi-asserted-by":"crossref","first-page":"102395","DOI":"10.1016\/j.autrev.2019.102395","article-title":"Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: a systematic review and meta-analysis","volume":"18","author":"Chock","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.thromres.2020.10.005_bb0700","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.lpm.2014.02.004","article-title":"ITP and international guidelines: what do we know, what do we need?","volume":"43","author":"Rodeghiero","year":"2014","journal-title":"Presse medicale (Paris, France\u202f: 1983)"},{"key":"10.1016\/j.thromres.2020.10.005_bb0705","first-page":"1","article-title":"Report of a \u2018consensus\u2019 on the lines of therapy for primary immune thrombocytopenia in adults, promoted by the Italian Gruppo di Studio delle Piastrine","author":"Cirasino","year":"2020","journal-title":"Platelets."},{"issue":"11","key":"10.1016\/j.thromres.2020.10.005_bb0710","first-page":"102395","article-title":"Adult immune thrombocytopenia and thrombopoietin receptor agonist: Ten years later","volume":"18","author":"Ebbo","year":"2019","journal-title":"La Revue de medecine interne"},{"key":"10.1016\/j.thromres.2020.10.005_bb0715","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","volume":"132","author":"Pengo","year":"2018","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2020.10.005_bb0720","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.thromres.2020.10.005_bb0725","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/rheumatology\/kex291","article-title":"The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: executive summary","volume":"57","author":"Gordon","year":"2018","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.thromres.2020.10.005_bb0730","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.thromres.2020.10.005_bb0735","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/annrheumdis-2018-213512","volume":"77","author":"Pons-Estel","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.thromres.2020.10.005_bb0740","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/rheumatology\/kex286","article-title":"The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults","volume":"57","author":"Gordon","year":"2018","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.thromres.2020.10.005_bb0745","first-page":"696","article-title":"Systemic lupus erythmatosus - when to consider and management options","volume":"42","author":"Apostolopoulos","year":"2013","journal-title":"Aust. Fam. Physician"},{"key":"10.1016\/j.thromres.2020.10.005_bb0750","article-title":"Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders","volume":"3","author":"Estcourt","year":"2016","journal-title":"The Cochrane database of systematic reviews"},{"key":"10.1016\/j.thromres.2020.10.005_bb0755","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1200\/JCO.2005.03.8877","article-title":"Thromboembolism in hospitalized neutropenic cancer patients","volume":"24","author":"Khorana","year":"2006","journal-title":"Journal of clinical oncology\u202f: official journal of the American Society of Clinical Oncology."},{"key":"10.1016\/j.thromres.2020.10.005_bb0760","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1160\/TH13-12-1020","article-title":"Implications of cytogenetics for venous thromboembolism in acute myeloid leukaemia","volume":"113","author":"Lee","year":"2015","journal-title":"Thromb. Haemost."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2020.10.005_bb0765","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0049-3848(20)30398-4","article-title":"Thrombosis in hematological malignancies: mechanisms and implications","volume":"191","author":"Horowitz","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.10.005_bb0770","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ams2.322","article-title":"The Japanese clinical practice guidelines for management of sepsis and septic shock 2016 (J-SSCG 2016)","volume":"5","author":"Nishida","year":"2018","journal-title":"Acute medicine & surgery."},{"key":"10.1016\/j.thromres.2020.10.005_bb0775","first-page":"234","article-title":"Thrombosis associated with viral hepatitis","volume":"2","author":"Galli","year":"2014","journal-title":"Journal of clinical and translational hepatology."},{"key":"10.1016\/j.thromres.2020.10.005_bb0780","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1213\/00000539-199712000-00016","article-title":"Phlegmasia cerulea dolens, cerebral venous thrombosis, and fatal pulmonary embolism due to heparin-induced thrombocytopenic thrombosis syndrome","volume":"85","author":"Beland","year":"1997","journal-title":"Anesth. Analg."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2020.10.005_bb0785","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/ijlh.13223","article-title":"Evolving concepts of pathogenesis of heparin-induced thrombocytopenia: diagnostic and therapeutic implications","volume":"42","author":"Chong","year":"2020","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.thromres.2020.10.005_bb0790","doi-asserted-by":"crossref","DOI":"10.1111\/trf.16018","article-title":"Therapeutic plasma exchange and intravenous immune globulin in the treatment of heparin-induced thrombocytopenia: a systematic review","author":"Onuoha","year":"2020","journal-title":"Transfusion."},{"key":"10.1016\/j.thromres.2020.10.005_bb0795","doi-asserted-by":"crossref","first-page":"509","DOI":"10.5694\/mja2.50213","article-title":"Diagnosis and management of heparin-induced thrombocytopenia: a consensus statement from the Thrombosis and Haemostasis Society of Australia and New Zealand HIT Writing Group","volume":"210","author":"Joseph","year":"2019","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.thromres.2020.10.005_bb0800","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood advances."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820305442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820305442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:47:15Z","timestamp":1758736035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384820305442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":160,"alternative-id":["S0049384820305442"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2020.10.005","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Why thromboembolism occurs in some patients with thrombocytopenia and treatment strategies","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2020.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}